NASA mission gets down to earth
Article Abstract:
The EOS, a multi-satellite project aimed at collecting data on the condition of the planet to aid future policy makers, is losing the support of both Congress and scientists. NASA is re-focusing research goals toward short-term effects and away from the global-change research.
Publication Name: Science
Subject: Science and technology
ISSN: 0036-8075
Year: 1995
User Contributions:
Comment about this article or add new information about this topic:
DOE to industry: so long, partner
Article Abstract:
The DOE is backing away from Cooperative Research and Development Agreements between its weapons labs and industry after a negative assessment of their value and budget cuts by Congress. The program began in 1990 and reached its height in 1994 with 185 agreements.
Publication Name: Science
Subject: Science and technology
ISSN: 0036-8075
Year: 1996
User Contributions:
Comment about this article or add new information about this topic:
Five-year plan squeezes R&D
Article Abstract:
A long-term budget projection under the budget agreement between the Clinton administration and Congress has no provisions for increases in science funding from 1998 to 2002. The plan will decrease research spending when inflation is considered.
Publication Name: Science
Subject: Science and technology
ISSN: 0036-8075
Year: 1997
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: New insights into the oxidative electrochemistry of vitamin E. Bond strengths of toluenes, anilines, and phenols: to hammett or not
- Abstracts: Scientists mobilize to fight cuts. An R&D victory, but for how long? Congress targets fusion, favors NIH
- Abstracts: Universities struggle with the legacy of Apartheid. Elite science in a poor country. South African research comes in from the cold
- Abstracts: Watson urges 'put Hitler behind us.' (Nobel Prize winner James D. Watson) Reactor project presses ahead despite protests
- Abstracts: Congress split on best way to reshape network of labs. Kessler's legacy: unfinished reform. FDA: Congress mixes harsh medicine